Crossmark

Clinical and biochemical characterization of asymptomatic carriers and symptomatic patients with hereditary transthyretin amyloidosis caused by TTR V30L mutation

Crossref DOI link: https://doi.org/10.1007/s10072-024-07765-5

Published Online: 2024-09-14

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiao, Hao

Wang, Mengdie

Du, Kang

Sun, Jialu

Chu, Xujun

Yang, Junsu

Lv, He

Zhang, Wei

Wang, Zhaoxia

Yuan, Yun

Liu, Yu https://orcid.org/0000-0002-0779-1488
Meng, Lingchao https://orcid.org/0000-0001-9822-1095
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82101469, 22222410, 22374148)

Science Fund for Distinguished Young Scholars of Dalian Province (2022RJ04)

National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital (22cz020301-4802068, 2024IR12)
License Information

Text and Data Mining valid from 2024-09-14

Version of Record valid from 2024-09-14
More Information

Article History

Received: 1 June 2024

Accepted: 2 September 2024

First Online: 14 September 2024

Declarations

:

: All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the appropriate institutional committee. And informed consent was obtained from all individual participants included in the study.

: All human research participants provided informed consent for publication of case details, images and any other personal information.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below